Physician profile
David M Engman
NPI 1891721098
$1,184,820.21
in general payments reported to CMS, 2019-2025
2 companies · $172K in 2025
The $172K reported for 2025 was more than what 99% of Clinical Pathology/Laboratory Medicine providers received nationally (typical 2025 total: $114).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48K · 2021: $174K · 2022: $201K · 2023: $315K · 2024: $275K · 2025: $172K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $746K · Travel and Lodging: $15K · Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $746,200.00 |
| Travel and Lodging | $14,689.59 |
| Food and Beverage | $1,351.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Diasorin INC. | $1,184,757.86 | 2020-2025 | Ivd - Various, Liaison |
| Roche Diagnostics Corporation | $62.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Engman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.